Arboretum_JD, Author at Arboretum Ventures

Hicuity Health News Page

Hicuity Health Introduces Guardian CI™ Telesitter

Hicuity Health, the nation’s leading provider of high-acuity telemedicine services, announced the launch of its…

Arboretum_JDMarch 24, 2021

Arboretum Home Page News Page

Innovative Healthcare Investor Nicole J. Walker Joins Arboretum Ventures

Arboretum Ventures, a leading healthcare venture capital firm, is excited to welcome nationally recognized healthcare…

Arboretum_JDMarch 24, 2021

Francis Medical News Page

For the Record with Michael Hoey, Founder and CTO, Francis Medical

Michael founded Francis Medical in 2018 where he serves as a director and chief technology…

Arboretum_JDMarch 23, 2021

Arboretum News Page

Diagnostics is About Prevention – Featuring Sundu Brahmasandra of NeuMoDx

Ann Arbor-based NeuMoDx™ Molecular Systems (a QIAGEN company) has been awarded the Startup Innovator Award…

Arboretum_JDMarch 19, 2021

Home Page News Page Swift Biosciences

Integrated DNA Technologies Acquires Swift Biosciences

Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced today the acquisition of…

Arboretum_JDMarch 11, 2021

Pear Therapeutics

Pear Therapeutics Announces Second Closing of Series D Financing

Pear Therapeutics, Inc., recently announced the second closing of its Series D financing. The second…

Arboretum_JDMarch 3, 2021

BioIQ News Page

BioIQ Launches New Telehealth Solution for Diagnostic Testing and Population Health

BioIQ, an analytics-driven population health and testing platform company for top employers and health plans,…

Arboretum_JDMarch 3, 2021

Fifth Eye Home Page News Page

Fifth Eye Receives FDA Clearance for Hemodynamic Monitoring Device

Fifth Eye, a provider of intuitive real-time clinical analytics, today announced the U.S. Food and…

Arboretum_JDMarch 2, 2021

Home Page News Page Strata Oncology

Strata Oncology Announces the Strata PATH Trial with Pfizer as First Pharma Partner

Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced…

Arboretum_JDMarch 2, 2021

EQRx News Page

EQRx’s partner, Hansoh Pharmaceuticals, Releases Topline Results of their Phase III Study for Aumolertinib

EQRx, a company committed to developing and delivering important new medicines at lower prices, announced…

Arboretum_JDFebruary 22, 2021

Arboretum_JD